Skip to main content
Unmet Need
Physicians
Clinical
About
News
Investors
Top Menu
Investor Relations
Investor Relations Menu
Overview
Stock Info
SEC Filings
News
Events & Presentations
Management
Corporate Governance
Investor Alerts
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers
More News
Aclarion Publishes 2026 Shareholder Letter from the Chairman
February 5, 2026
2026 Annual Shareholder Letter from the Chairman
February 5, 2026
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation
February 3, 2026
Unmet Need
Physicians
Clinical
About
News
Investors
